- Home
- FSBC vs XNCR Comparison
FSBC vs XNCR Comparison
Compare FSBC & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FSBC | XNCR |
|---|---|---|
| Founded | 2002 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 860.4M | 881.9M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | FSBC | XNCR |
|---|---|---|
| Price | $41.90 | $11.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $41.90 | $22.33 |
| AVG Volume (30 Days) | 74.7K | ★ 712.4K |
| Earning Date | 04-27-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.47% | N/A |
| EPS Growth | 28.32 | ★ 65.36 |
| EPS | ★ 0.87 | N/A |
| Revenue | N/A | ★ $125,576,000.00 |
| Revenue This Year | $30.25 | N/A |
| Revenue Next Year | $12.30 | $4.80 |
| P/E Ratio | $48.28 | ★ N/A |
| Revenue Growth | N/A | ★ 13.65 |
| 52 Week Low | $26.26 | $6.92 |
| 52 Week High | $42.26 | $18.69 |
Technical Indicators
Market Signals| Indicator | FSBC | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 60.54 | 42.24 |
| Support Level | $39.93 | $11.02 |
| Resistance Level | N/A | $13.28 |
| Average True Range (ATR) | 1.00 | 0.72 |
| MACD | 0.03 | -0.16 |
| Stochastic Oscillator | 78.74 | 24.53 |
Price Performance
Historical ComparisonAbout FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.